[PROPERDIN AND CANCER. II. CHANGES IN THE ASPECIFIC DEFENSES OF THE ORGANISM DURING ANTIBLASTIC CHEMOTHERAPY].
D000230:Adenocarcinoma; D000970:Antineoplastic Agents; D002294:Carcinoma, Squamous Cell; D003110:Colonic Neoplasms; D003520:Cyclophosphamide; D005260:Female; D005833:Genital Neoplasms, Female; D006801:Humans; D008207:Lymphatic Metastasis; D009369:Neoplasms / Q000276:immunology* / Q000532:radiotherapy* / Q000628:therapy*; D010534:Peritoneal Neoplasms; D011414:Properdin; D012509:Sarcoma
D000970:Antineoplastic Agents; D011414:Properdin; D003520:Cyclophosphamide
ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CARCINOMA, EPIDERMOID; COLONIC NEOPLASMS; CYCLOPHOSPHAMIDE; GYNECOLOGIC NEOPLASMS; LYMPHATIC METASTASIS; NEOPLASM IMMUNOLOGY; NEOPLASM RADIOTHERAPY; NEOPLASM THERAPY; PERITONEAL NEOPLASMS; PROPERDIN; SARCOMA
PROPERDINA E CANCRO. II. VARIAZIONI DELLE DIFESE ASPECIFICHE DELL'ORGANISMO IN CORSO DI CHEMIOTERAPIA ANTIBLASTICA.